Atlas Trials

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Clinical trial NCT01805375 · COMPLETED

Trial details

NCT number
NCT01805375
Sponsor
Cancer Research UK
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Indolent B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinaemia
Start date
2013-04-01
Primary completion
2017-12-14
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.